Expression of E-cadherin and B-cell lymphoma 2 in oral cancer: A ratio-based planning for targeted therapy

Expression of E-cadherin and B-cell lymphoma 2 in oral cancer: A ratio-based planning for targeted therapy

Background: Oral cancer is known to be governed by the antiapototic and loss of cell adhesion properties which dictate its progression. Aim: To study the immunexpression of E-cadherin and Bcl-2 in varying TNM stages and histopathological grades of OSCC. Materials and Methods: 11 cases of well differ...

Full description

Bibliographic Details
Main Authors:	Nikita Gulati, Ajit Singh Rathore, Saurabh Juneja, Priyanka Rastogi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Indian Journal of Dental Research
Subjects:	B-cell lymphoma 2 E-cadherin oral squamous cell carcinoma prognosis
Online Access:	http://www.ijdr.in/article.asp?issn=0970-9290;year=2017;volume=28;issue=1;spage=3;epage=9;aulast=Gulati

Similar Items

Correlation of E-cadherin immunohistochemical expression with histopathological grading of oral squamous cell carcinoma
by: Sandhya Singh Kushwaha, et al.
Published: (2019-01-01)

Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma
by: Jaishree Sharma, et al.
Published: (2022-01-01)

Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma
by: Samer George Hakim, et al.
Published: (2023-05-01)

Immunohistochemical Expression of the Epithelial to Mesenchymal Transition Proteins E-cadherin and β-catenin in Grades of Oral Squamous Cell Carcinoma
by: Vijay Kumar, et al.
Published: (2021-01-01)

A study of E-cadherin expression in esophageal carcinoma
by: C P Manjula, et al.
Published: (2023-01-01)

Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma
by: Liana Cristina Melo Carneiro COSTA, et al.
Published: (2015-04-01)

Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells
by: Stephanie A. Sheehan, et al.
Published: (2022-02-01)

E-cadherin as a Prognostic Biomarker in Oral Squamous Cell Carcinoma: A Pilot Study at Tertiary Care Hospital
by: H R Khan, et al.
Published: (2022-01-01)

Effect of CDH1 and CDH2 genes polymorphisms in oral squamous cell carcinoma susceptibility in a sample of Iranian population: A case‐control study
by: Hamideh Kadeh, et al.
Published: (2023-04-01)

Comparative Assessment of E-cadherin’s Expression between the Metastatic and Non-metastatic Oral Squamous Cell Carcinoma: An Immunohistochemical Study
by: Sufia Khan, et al.
Published: (2023-10-01)

T-Cadherin Expression in Actinic Keratosis Transforming to Invasive Squamous Cell Carcinoma
by: Stanislaw A. Buechner, et al.
Published: (2019-01-01)

Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: An immunohistochemical study
by: Kaur Gurkiran, et al.
Published: (2009-01-01)

CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells
by: Jian Xie, et al.
Published: (2023-05-01)

Effects of systemic administration of HESA-A on the expression of cyclin D1 and EGFR and E-cadherin in the induced tongue dysplasia in rats
by: Shirin Fattahi, et al.
Published: (2017-12-01)

Expression and Significance of Cadherins and Its Subtypes in Development and Progression of Oral Cancers: A Review
by: Yogesh Chand Rajwar, et al.
Published: (2015-05-01)

“Switch of E-Cadherin to N-Cadherin expression in different molecular subtypes of breast invasive duct carcinomas and its correlation with clinicopathological features”
by: Mayada S Farrag, et al.
Published: (2021-01-01)

COMPARISON OF EXPRESSION OF E-CADHERIN IN ORAL PSEUDOEPITHELIOMATOUS HYPERPLASIA AND ORAL SQUAMOUS CELL CARCINOMA
by: Ayesha Mukhtar Awan, et al.
Published: (2019-09-01)

Utility of DNA-specific stains in micronuclei assay as a marker of genotoxicity in oral potentially malignant disorders and oral squamous cell carcinoma
by: Saurabh Juneja, et al.
Published: (2019-01-01)

A Valuable System with High Speci fi city for Evaluating both Metastasis and Prognosis of Oral Squamous Cell Carcinoma
by: Jianming ZHANG, et al.
Published: (2009-04-01)

SURVIVIN EXPRESSION IN ORAL SQUAMOUS CELL CARCINOMA
by: Antunovic Marija, et al.
Published: (2023-09-01)

Prognostic value of pretreatment lymphocyte‐to‐monocyte ratio in patients with advanced oral cavity cancer
by: Pasawat Supanimitjaroenporn, et al.
Published: (2022-06-01)

Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma
by: Lorenzo Fernandes Moça Trevisani, et al.
Published: (2023-10-01)

Association of Kaiso and partner proteins in oral squamous cell carcinoma
by: Hira Salam, MDS, et al.
Published: (2023-08-01)

Histopathological differences between genders in patients with oral squamous cell carcinoma
by: Fábio Muradás Girardi, et al.
Published: (2017-09-01)

Histopathological differences between genders in patients with oral squamous cell carcinoma
by: Fábio Muradás Girardi, et al.
Published: (2017-09-01)

Prognosis and Nomogram Prediction for Patients with Oral Squamous Cell Carcinoma: A Cohort Study
by: Xin-Yuan Zhang, et al.
Published: (2023-05-01)

LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice
by: Eline J. ter Steege, et al.
Published: (2023-01-01)

Detection of Helicobacter pylori in Oral Lesions
by: Soussan Irani, et al.
Published: (2013-12-01)

Establishment of a prognostic model based on proliferation-related genes in oral squamous cell carcinoma
by: GUO Junfeng, et al.
Published: (2020-09-01)

Genistein elicits its anticancer effects through up-regulation of E-Cadherin in Acute Lymphoblastic Leukemia (ALL) cells: an in vitro experimental study
by: Vahideh Namordizadeh, et al.
Published: (2019-03-01)

Age related changes in clinicopathologic features of oral squamous cell carcinoma (OSCC) in Iranian patients: An epidemiologic study
by: Ramin Ghafari, et al.
Published: (2018-06-01)

Elevated red blood cell distribution width predicts poor prognosis in patients with oral squamous cell carcinoma
by: Ge W, et al.
Published: (2018-09-01)

Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
by: Studer Gabriela, et al.
Published: (2011-06-01)

Immunohistochemical evaluation of E-cadherin expression in basal cell carcinoma of the skin
by: Vladimír Bartoš, et al.
Published: (2015-08-01)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
by: Myung-Giun Noh, et al.
Published: (2017-08-01)

VISTA H-Score Is Significantly Associated with a 5-Year DFS Rate in Oral Squamous Cell Carcinoma
by: Anna Starzyńska, et al.
Published: (2023-02-01)

Conditional ablation of E‐cadherin in the oral epithelium progeny results in tooth anomalies
by: Stephanos Kyrkanides, et al.
Published: (2022-10-01)

Tissue eosinophilia in oral and cutaneous squamous cell carcinoma and normal oral and cutaneous tissues
by: Reyhane Kargar, et al.
Published: (2017-07-01)

Downregulation of E‐cadherin immunohistochemical expression - Highlights its role in epithelial- to-mesenchymal transition in breast carcinomas
by: Mohammad Adil, et al.
Published: (2023-01-01)

Prognostic value of absolute lymphocyte count in oral cavity squamous cell carcinoma
by: Rema Shah, et al.
Published: (2023-08-01)